Who owns PHARVARIS N V?
- Ticker: PHVS
- CUSIP Number: n69605108
Tip: Access positions for across all investors
Analyze quarterly positions in Pharvaris N V with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pharvaris N V stock
Who bought or sold PHARVARIS N V this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| General Atlantic | 8.0M | $223M | 0% | Dec 2025 |
|
| FMR | 6.4M | $178M | 0% | Dec 2025 |
|
| Foresite Capital Management IV | 4.8M | $135M | 0% | Mar 2026 |
|
| venBio Partners | 4.6M | $131M | 0% | Mar 2026 |
|
| Viking Global Investors | 3.7M | $103M | 0% | Mar 2026 |
|
| EQT Fund Management S.a r.l. | 3.4M | $95M | 0% | Dec 2025 |
|
| Deerfield Management Company | 3.1M | $88M | 0% | Mar 2026 |
|
| Bain Capital Life Sciences Investors | 2.7M | $76M | -5% | Mar 2026 |
|
| Commodore Capital | 1.9M | $54M | 2% | Mar 2026 |
|
| Wellington Management Company | 1.9M | $53M | 10% | Dec 2025 |
|
| Novo A/S | 1.8M | $49M | 0% | Mar 2026 |
|
| Saturn V Capital Management | 1.1M | $32M | 29% | Dec 2025 |
|
| Point72 Asset Management | 1.0M | $28M | 42% | Mar 2026 |
|
| Cormorant Asset Management | 1.0M | $28M | -8% | Mar 2026 |
|
| Sofinnova Ventures | 818k | $23M | 10% | Mar 2026 |
|
| 5AM Venture Management | 798k | $23M | 0% | Mar 2026 |
|
| BlackRock | 757k | $21M | 7% | Mar 2026 |
|
| Soleus Capital Management | 702k | $20M | 0% | Mar 2026 |
|
| Rock Springs Capital Management | 646k | $18M | 4% | Mar 2026 |
|
| Kynam Capital Management | 640k | $18M | 0% | Mar 2026 |
|
| Patient Square Capital | 493k | $14M | -9% | Mar 2026 |
|
| Ikarian Capital | 487k | $14M | 0% | Mar 2026 |
|
| Elmind Capital | 476k | $13M | 100% | Mar 2026 |
|
| Balyasny Asset Management | 462k | $13M | -7% | Mar 2026 |
|
| Eversept Partners | 439k | $12M | 100% | Dec 2025 |
|
| Baker Bros. Advisors | 375k | $11M | 0% | Mar 2026 |
|
| D. E. Shaw & Co | 321k | $9.1M | 23% | Mar 2026 |
|
| Polar Capital Holdings | 238k | $6.6M | -10% | Dec 2025 |
|
| Polygon Management | 222k | $6.3M | 14% | Mar 2026 |
|
| OrbiMed Advisors | 205k | $5.8M | 0% | Mar 2026 |
|
| Kalehua Capital Management | 199k | $5.6M | 100% | Mar 2026 |
|
| Foresite Capital Management V | 194k | $5.5M | 100% | Mar 2026 |
|
| Millennium Management | 182k | $5.1M | -27% | Mar 2026 |
|
| Seven Fleet Capital Management | 173k | $4.9M | 212% | Mar 2026 |
|
| Citadel Advisors | 169k | $4.8M | 25% | Mar 2026 |
|
| Jones Hill Capital | 167k | $4.7M | 100% | Mar 2026 |
|
| Octagon Capital Advisors | 165k | $4.7M | -75% | Mar 2026 |
|
| Morgan Stanley | 164k | $4.6M | -34% | Mar 2026 |
|
| HighVista Strategies | 162k | $4.5M | 100% | Dec 2025 |
|
| State Street Corporation | 162k | $4.5M | 13% | Dec 2025 |
|
| Schroder Investment Management Group | 158k | $4.1M | 1209% | Dec 2025 |
|
| Boothbay Fund Management | 157k | $4.4M | 0% | Mar 2026 |
|
| Goldman Sachs Group | 143k | $4.0M | -11% | Mar 2026 |
|
| Two Sigma Investments | 126k | $3.6M | -41% | Mar 2026 |
|
| Alyeska Investment Group | 125k | $3.5M | 0% | Mar 2026 |
|
| Susquehanna International | 122k | $3.4M | 100% | Dec 2025 |
|
| ADAR1 Capital Management | 106k | $3.0M | 23% | Mar 2026 |
|
| Squarepoint Ops | 96k | $2.7M | -4% | Mar 2026 |
|
| Geode Capital Management | 89k | $2.5M | 3% | Mar 2026 |
|
| Stempoint Capital | 87k | $2.4M | 48% | Mar 2026 |
|
| Dr. Jeffrey R. Jay, M.D. | 83k | $2.3M | 0% | Mar 2026 |
|
| Northern Trust | 81k | $2.2M | 4% | Dec 2025 |
|
| Ubs Global Asset Management Americas | 78k | $2.2M | -8% | Mar 2026 |
|
| UBS Group | 72k | $2.0M | -48% | Mar 2026 |
|
| Trexquant Investment | 66k | $1.9M | -22% | Mar 2026 |
|
| Logos Global Management | 65k | $1.8M | -35% | Mar 2026 |
|
| TD Asset Management | 55k | $1.5M | -54% | Mar 2026 |
|
| Deutsche Bank Aktiengesellschaft | 54k | $1.5M | -5% | Mar 2026 |
|
| ALPS Advisors | 52k | $1.5M | -1% | Mar 2026 |
|
| Jane Street | 45k | $1.3M | -47% | Mar 2026 |
|
| Swiss National Bank | 45k | $1.3M | 0% | Mar 2026 |
|
| Manufacturers Life Insurance Company | 44k | $1.2M | -45% | Mar 2026 |
|
| Marshall Wace | 32k | $883k | 17% | Dec 2025 |
|
| Amundi | 31k | $874k | 12% | Mar 2026 |
|
| Tudor Investment Corporation | 31k | $873k | -4% | Mar 2026 |
|
| Birchview Capital | 30k | $843k | 0% | Mar 2026 |
|
| SummitTX Capital | 29k | $824k | 28% | Mar 2026 |
|
| Quadrature Capital | 29k | $803k | 100% | Dec 2025 |
|
| Hrt Financial | 28k | $780k | 87% | Mar 2026 |
|
| Legal & General Group | 27k | $756k | 18% | Mar 2026 |
|
| Jump Financial | 26k | $730k | 100% | Dec 2025 |
|
| California State Teachers Retirement System | 24k | $682k | 1% | Mar 2026 |
|
| Palumbo Wealth Management | 21k | $582k | 2% | Mar 2026 |
|
| PSP Research | 20k | $565k | -2% | Mar 2026 |
|
| Vanguard Group | 19k | $536k | 0% | Dec 2025 |
|
| XTX Topco | 19k | $515k | 126% | Dec 2025 |
|
| Verition Fund Management | 18k | $497k | 100% | Dec 2025 |
|
| Nuveen | 17k | $480k | 0% | Mar 2026 |
|
| Bank of America Corporation | 16k | $442k | 100% | Mar 2026 |
|
| Vanguard Asset Management | 15k | $425k | 100% | Mar 2026 |
|
| Qube Research & Technologies | 15k | $408k | 100% | Dec 2025 |
|
| China Universal Asset Management | 11k | $321k | 9% | Mar 2026 |
|
| Occudo Quantitative Strategies | 11k | $352k | -8% | Mar 2026 |
|
| Virtus Investment Advisers | 11k | $306k | 67% | Dec 2025 |
|
| Alliancebernstein | 9.0k | $249k | 0% | Mar 2026 |
|
| Police & Firemen's Retirement System of New Jersey | 8.2k | $233k | 0% | Mar 2026 |
|
| Teacher Retirement System Of Texas | 8.2k | $231k | -8% | Mar 2026 |
|
| Persistent Asset Partners | 7.9k | $223k | 100% | Mar 2026 |
|
| Ohio Pers | 7.6k | $210k | 21% | Dec 2025 |
|
| Vanguard Investments Australia | 6.1k | $172k | 100% | Mar 2026 |
|
| Klp Kapitalforvaltning As | 5.8k | $164k | 0% | Mar 2026 |
|
| Bnp Paribas Investment Partners | 5.5k | $153k | 69% | Dec 2025 |
|
| Nano Cap New Millennium Growth Fund | 5.0k | $139k | 100% | Dec 2025 |
|
| Zurcher Kantonalbank | 4.0k | $112k | 0% | Mar 2026 |
|
| Mirae Asset Global Investments | 3.3k | $94k | 7% | Mar 2026 |
|
| Barclays | 2.8k | $77k | 100% | Dec 2025 |
|
| Citigroup | 2.4k | $69k | 100% | Mar 2026 |
|
| Quantbot Technologies | 2.4k | $68k | -44% | Mar 2026 |
|
| Gf Fund Management | 1.4k | $41k | 14% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 1.4k | $39k | -98% | Mar 2026 |
|
| Tower Research Capital | 471.00 | $13k | 100% | Dec 2025 |
|
| Wells Fargo & Company | 450.00 | $13k | 0% | Mar 2026 |
|
| Centerpoint Advisors | 100.00 | $3.0k | 0% | Mar 2026 |
|
| Royal Bank of Canada | 81.00 | $2.0k | 7% | Mar 2026 |
|
| Caitong International Asset Management | 18.00 | $507.999600 | 200% | Mar 2026 |
|
| SBI Securities | 1.00 | $28.000000 | 0% | Mar 2026 |
|
Who sold out of Pharvaris N V?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Integral Health Asset Management | Sep 2025 | 200k | $5.0M |
| Silverarc Capital Management | Sep 2025 | 184k | $4.6M |
| Two Sigma Advisers | Dec 2025 | 90k | $2.5M |
| Sphera Funds Management | Dec 2025 | 64k | $1.8M |
| Jpmorgan Chase & Co | Sep 2025 | 27k | $676k |
| Quarry | Sep 2025 | 442.00 | $11k |
| Daiwa Securities Group | Dec 2025 | 213.00 | $6.0k |